The clinical features and prognosis of non-Langerhans cell histiocytosis (non-LCH) remained poorly defined. Although recurrent somatic activating mutations of BRAFV600E and additional genetic drivers
In brief, it is firstly report that WT1 p.Arg370Pro and TET2 p.Asp1844Asn variants co-existed in a refractory and recurrent AML patient by inheritance. These two variants of patient were replaced with
FFPE Bone marrow core biopsis of a cohort of 16 APMF Samples were analysed by OncoScan copy number analysis (E-MTAB-7888). 5 out of this 16 Samples had enough DNA available for NGS using the Illumina
